StreetAlpha.app
Home › Stocks › KOD

Kodiak Sciences Inc. (KOD)

Healthcare
$97.17
▼ −0.75%
LAST CLOSE · NOV 20

Kodiak Sciences develops drug treatments for retinal eye diseases, with its lead candidate still in clinical trials. It last closed at $97.17 on Nov 20, down 0.75% on the day. The next earnings report for KOD is expected around Tue, Mar 30, 2027, after the close. For the quarter ended Sep 2026, KOD reported EPS of -$1.05. Over its last 8 reports the stock moved an average of 8.1% the session after earnings. Over the last 12 months KOD insiders bought $241.3M of stock on the open market and sold $4.9M, according to SEC Form 4 filings.

AI Auto Pilots
Is KOD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold KOD.

Key Stats

Last 12 months
Results
Net income
−$246.8M
EPS (diluted)
−$4.08
Free cash flow
−$172.8M
Valuation
Market cap
$6.4B
65.4M shares
P/E
–
No P/E while losing money
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$88.7M
At Sep 30
Shareholder equity
$12.6M
Shares outstanding
65.4M
At Nov 9
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: −$267.0M−$267.0MFY2021FY2022: −$333.8M−$333.8MFY2022FY2023: −$260.5M−$260.5MFY2023FY2024: −$176.2M−$176.2MFY2024FY2025: −$230.0M−$230.0MFY2025

From KOD's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 12). Last 12 months adds up the four latest quarters.

Next report
Mar 30
Estimated date · After the close
Reported EPS
-$1.05
Quarter ended Sep 2026
Year ago EPS
-$1.16
Same quarter last year
Revenue
—
Last reported quarter
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: -$0.84Dec '24Mar 2025: -$1.09Mar '25Jun 2025: -$1.03Jun '25Sep 2025: -$1.16Sep '25Dec 2025: -$1.04Dec '25Mar 2026: -$0.94Mar '26Jun 2026: -$1.05Jun '26Sep 2026: -$1.05Sep '26Latest -$1.05
Revenue by quarter
Not enough quarters on file yet.
How KOD moved after its last 8 reports
Average move the session after a report ±8.1%
Nov 12, 2026After the close+2.7%
Aug 13, 2026After the close+3.4%
May 7, 2026After the close−6.1%
Mar 31, 2026After the close+12.3%
Nov 13, 2025After the close+3.4%
Aug 13, 2025After the close+16.5%
May 14, 2025After the close−15.5%
Mar 27, 2025After the close−4.9%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on KODStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on KOD
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on KOD

Technical Analysis

KOD · as of the Nov 20 close · updated each morning
Uptrend

The stock sits between its 20 and 50 day averages. It is 51% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 52). The nearest support is the Pivot S1 at $95.50, and the nearest resistance the Pivot at $98.19.

Short trendBullish
Long trendBullish
MomentumFading
StretchNormal
VolatilityNormal, 6.8%/day
Key levels
$112.7952 week high+16.1%
$103.27Swing high (Oct 12)+6.3%
$99.8620 day average+2.8%
$99.86Pivot R1+2.8%
$98.19Pivot+1.0%
$97.17Last close
$95.50Pivot S1−1.7%
$94.62Swing low (Nov 17)−2.6%
$83.1350 day average−14.4%
$61.55100 day average−36.7%
$47.81200 day average−50.8%
$19.2552 week low−80.2%
Indicators
RSI (14)52.04Middle of its rangeNeutral
MACD4.24Below its signal lineBearish
Stochastic32.0Middle of its rangeNeutral
ADX (14)25.6Trending up
Williams %R-70.1Oversold below −80, overbought above −20Neutral
CCI (20)-25.6Oversold below −100, overbought above 100Neutral
Rate of change−2.1%Change over 10 sessionsBearish
ATR (14)$6.64Typical daily range, 6.8% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for KOD

What happened before

See how KOD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow KOD usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How KOD has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2018.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for KODHow many large options trades hit KOD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

Dark Pool

30D
Prints
Notional
Largest print
Loading…

KOD Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●111 buying vs 112 selling
  • ●Held by funds -0.2 pts
  • ▲Funds holding +17
  • ●Superinvestors: 2 added, 2 cut
  • ▼Put/call 0.33 to 0.70
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding217200+8.5%
In funds' top 10107+42.9%
Held by funds92.3%92.5%−0.2 pts
New / increased51 / 6035 / 81−4.3%
Reduced / sold out78 / 3455 / 24+41.8%
Put/call ratio0.700.33+107.9%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See KOD institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

KOD Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$241.3M5 buys · 2 insiders
Sold$4.9M3 sales · 1 insider
100% of the selling was under pre-arranged trading plans.
2025-12 bought $60.0M2026-04 sold $1.2M2026-06 sold $1.0M2026-09 bought $157.0M2026-10 sold $2.7M2026-11 bought $24.3MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 5Baker Bros. Advisors LPDirectorBuy247,090$98.51$24.3M
Oct 21John A. BorgesonCFOSale plan30,000$90.01$2.7M
Sep 29Baker Bros. Advisors LPDirectorBuy715,592$88.59$63.4M
Sep 28Baker Bros. Advisors LPDirectorBuy807,840$72.57$58.6M
Sep 28Baker Bros. Advisors LPDirectorBuy418,323$83.58$35.0M
Jun 4John A. BorgesonCFOSale plan30,000$34.10$1.0M
Every insider buy and sale for KOD over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See KOD insider trades →

From SEC Form 4 filings by KOD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether KOD is in one of them and how their past KOD trades turned out.

KOD in the AI portfolios
Loading…

KOD News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered KOD in an article yet. Here's the latest on the wider market.

KOD in the news

KOD Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Dec 12
Who traded KOD · since 2022
Latest 2 filings
$1K – $15KTraded Nov 8, 2022Filed Dec 12, 2022
$1K – $15KTraded Jul 18, 2022Filed Sep 9, 2022
PersonTypeAmountTradedFiledDelay
Christopher JacobsR · NYSell$1K – $15KNov 8, 2022Dec 12, 202234 d
Christopher JacobsR · NYBuy$1K – $15KJul 18, 2022Sep 9, 202253 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Kodiak Sciences

Kodiak Sciences is a biotechnology company based in Palo Alto, California, that develops drugs for diseases of the retina, the light sensitive tissue at the back of the eye. Its candidates are built on its Antibody Biopolymer Conjugate platform, which is designed to keep drugs active in the eye for longer. The lead candidate, tarcocimab, is in Phase 3 trials for conditions such as wet macular degeneration and diabetic retinopathy and has not yet been approved for sale.

Headquarters
Palo Alto, CA